InsidersTradesSigma
Explore the detailed record of transactions filed by Iranna S Bavalatii, Executive. Director active across 1 company, notably Gland Pharma Limited. Aggregated, 7 disclosures have been published. History available since 24 May 2021. The latest transaction was disclosed on 28 June 2022 (Sale). Regulator: SEBI (PIT + SAST). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Iranna S Bavalatii is an executive at Gland Pharma Limited, where he is responsible for managing the company's operations and strategy. Gland Pharma Limited is engaged in the manufacturing of pharmaceutical products. Iranna plays a key role in optimizing production processes and developing new medications.